SUMMARY A case of myxoma of the mitral valve is reported. The clinical features were indistinguishable from left atrial myxoma with prolapse through the mitral valve. Because of the known tendency for these tumours to recur it was treated by wide excision which necessitated replacement of the mitral valve. Myxomas, though rare, are the most common intracavitary cardiac tumours and account for over half of all primary cardiac neoplasms (Heath, 1968) . The great majority occur in the left and right atria, usually arising from the vicinity of the fossa ovalis. Myxomas may rarely be found in other regions of the heart such as the right (Gottsegen et al., 1963) and left (Kay et al., 1959) ventricles and Prichard's extensive review of the subject in 1951 included reference to a primary myxoma of the mitral valve.
The purpose of this report is to document an unusual case of myxoma of the mitral valve and describe how surgical management was influenced 'Present address: Royal Liverpool Children's Hospital, Myrtle Street, Liverpool L7 7DG. by consideration of the malignant potential of these tumours. (Yater, 1931) .
Atrial myxomas usually present with embolism, obstruction, or constitutional illness (Goodwin, 1963) . The obstructive symptoms and clinical presentation of myxoma of the mitral valve are indistinguishable from that of one which arises on the atrial septum and prolapses through the mitral valve. The presence of a filling defect is usually apparent at angiocardiography, but this is sometimes missed and the diagnosis can usually be confirmed by echocardiography (Popp and Harrison, 1969) .
Until relatively recently the accepted surgical management for intracardiac myxomas was simple excision of the tumour (Firor et al., 1966) . However, since Gerbode and colleagues (1967) reported the first case of recurrent left atrial myxoma, there have been several reports of tumour recurrence, both at and remote from the site of excision (Bahl et Hattler et al., 1970; Walton et al., 1972; Jugdutt et al., 1975) . The cause of recurrence is not clear and has been attributed to local implantation of cells by the primary tumour (Kabbani and Cooley, 1973) and the systemic embolisation of myxoma cells (Read et al., 1974) . Several reports have drawn attention to an unusually rapid growth rate of the recurrent tumour, and Walton and colleagues (1972) described an interesting case in which recurrence occurred within 22 months at the site of removal of the previous tumour, despite excision of a surrounding cuff of atrial septum. Careful histological examination of the piece of septum removed at the initial operation failed to show any tumour cells and they suggested that recurrence might have been from growth from 'pre-tumour' cells in this area. The malignant potential of atrial myxoma was stressed in a review of recurrent tumours by Read and colleagues (1974) , and they described one patient who developed metastatic myxomas in the sternum and pelvis 6 years after excision of an atrial myxoma. The metastatic tumours appeared histologically more cellular, pleomorphic, and malignant, but were otherwise similar to the original atrial tumour. These authors also reported the first patient on record to develop a recurrent myxoma on his mitral valve, for which valve replacement was required.
Because of the prevailing uncertainty with regard to the prognosis of these tumours, we agree with Kabbani and Cooley (1973) We are grateful to Dr P. G. I. Stovin for interpretation of the histological findings.
